Staphylococcus aureus (S. aureus) is a common pathogen that can cause high mortality and morbidity. Every year, many people die from S. aureus related infections. Methicillin resistant S. aureus (MRSA) strain is typically responsible for severe and complicated infections in human beings. For this reason it is also considered as one of the "Superbug". It is resistant to many drugs and the glycopeptide vancomycin is the only available antibiotic that is active against MRSA infections. However, recent reports indicate that vancomycin intermediate-resistant MRSA strains are emerging worldwide. Therefore, there is a concern that MRSA would gradually become fullyresistant to vancomycin in the near future and newer treatment strategies or compounds that can effectively cure S. aureus related infections should be well underway before our last antibiotic runs out. Plants have been naturally used since the ancient times as medicine and still many plant compounds can be found in the treatment of major ailments such as malaria and cancer. Due to multi-drug resistance problems in clinical settings and the need for newer compounds, there is great interest in phytochemical research because of their hypothesized and proven antimicrobial activities. Combinations of synergistic phytochemicals and antibiotics are assumed to be a new option to solve the drug resistance problem. Their combination can increase the efficacy and the killing rate and the chance of resistance development can be delayed. In this study, the effects of using conventional antibiotics in combination with phytochemicals were studied by using checker board methods and time-kill assays using 12 S. aureus strains. Studies suggested that tannic acid was synergistic with fusidic acid, minocycline, cefotaxime and rifampicin and additive with ofloxacin and vancomycin. Quercetin showed synergism with minocycline, fusidic acid and rifampicin. In a particular treatment option, the stability of the compounds (drugs or phytochemicals) is important as it selects resistance development in bacteria. The stability and the effectiveness of conventional antibiotics or phytochemicals were studied by inducing single-step adaptive resistant development in MRSA. The duration it took to get phenotypic mutant strains for a particular drug/phytochemical

Emergence and rapid spread of antibiotic resistance has become one of the leading causes of treatment failures in case of bacterial infections. Antibiotic combinations are generally used to enhance the overall efficacy of therapy with the aim to generate synergistic outcomes. It further helps in reduction of total antibiotic dosage. Phytochemicals are known to have multiple bacterial targets that modulate or modify resistance in bacteria. In the present study, a microchannel-based device and monitoring system was used to demonstrate and investigate short and long term effects of antibioticphytochemical combinations in different proportions on Staphylococcus aureus as test organism. Novel and unconventional combinations of antibiotic ciprofloxacin with the phytochemicals, quercetin, rutin, protocatechuic acid and ethyl gallate, were tested. Based on the experimental results, the strains exposed the antibiotic, generated resistant strains in four days, with 8 to 64 fold increase in their minimum inhibitory concentration (MIC) from the parent strain. The strains exposed to antibioticphytochemical combinations, however, showed no resistance causing mutations. The results were verified by standard laboratory practices such as disk-diffusion, mutation frequency, population profiling and molecular studies on the exposed strains. The phytochemicals were able to potentiate antibiotic activity; thereby, increasing the antibacterial efficacy and time span of the treatment with a common antibiotic.